GMP LVV Manufacturing
End-to-end GMP lentiviral vector manufacturing for cell and gene therapy programs, supporting both suspension and adherent production, with over 200 GMP manufacturing track records.
Lentiviral Vector CDMO Services Powered by Advanced Suspension Manufacturing
Proven Experience
ProBio's commercialization experience includes supporting global clients, CAR-T/TCR-T programs, and over 200 GMP manufacturing batches.
Increased Yields
The PowerS™-293T platform provides a 4 – 5 times yield improvement compared with adherent culture systems, enabling manufacturing cost reductions of 50%.
Scaling Confidence
Our proprietary suspension platform supports processes up to 200L and is designed for scalable manufacturing.
Platform Supports Adherent and Suspension Manufacturing
Case Studies
From 4L to 48L: Achieving Consistent High-Purity LVV Production with ProBio's Platform
Achieving Higher Lentiviral Vector Productivity with PowerS™-293T Cells and LentiHelper™ Plasmids
2-15× Higher LVV Titers with ProBio's PowerS™-293T Suspension Platform
Resources
FLYER
Viral Vector Packaging for tLVV, LVV, and AAV
Explore IND‑ready manufacturing, combining targeted vector design, robust process development, and streamlined timelines for various viral vectors.
FLYER
IND-enabling tLVV for In vivo CAR-T
Read about advanced targeted lentiviral vector solutions for In vivo CAR-T, and how phase-appropriate support is provided.
FLYER
Cell Therapy: Plasmid and Lentiviral Vector
Discover an integrated solution from plasmid to LVV, at high quality and speed.
WHITE
PAPER
Design of Targeting Lentiviral Vectors and Their Producer Cells for in vivo CAR-T
Learn about successful tLVV design, manufacturing, and downstream application for in vivo CAR-T.
Frequently Asked Questions